日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Clinical and translational results from the phase II ABACO trial evaluating the activity of cabozantinib in pretreated patients with metastatic colorectal cancer

评估卡博替尼在既往接受过治疗的转移性结直肠癌患者中疗效的 II 期 ABACO 试验的临床和转化结果

De Falco, V; Vitiello, P P; Ciardiello, D; Grasso, G; Mariella, E; Martini, G; Napolitano, S; Cardone, C; Arrichiello, G; Varriale, E; Di Bisceglie, M; Latiano, T; Maiello, E; Reginelli, A; Brunese, M C; Cappabianca, S; Del Tufo, S; Orlando, A; Nicastro, A; Caraglia, F; Esposito, L; Renato, D; Avallone, A; Orditura, M; Fazio, N; Curigliano, G; Zampino, M G; Bardelli, A; Ciardiello, F; Troiani, T; Martinelli, E

HER-2 gene alterations as biomarker in patients with metastatic colorectal cancer treated with FOLFIRI + cetuximab: findings from the CAPRI-2 GOIM study

HER-2基因改变作为接受FOLFIRI联合西妥昔单抗治疗的转移性结直肠癌患者的生物标志物:CAPRI-2 GOIM研究结果

Ciardiello, D; Boscolo Bielo, L; Napolitano, S; Martinelli, E; Troiani, T; Cioli, E; Latiano, T P; Maiello, E; Parente, P; Avallone, A; De Stefano, A; Bordonaro, R; Russo, A E; Lotesoriere, C; Vallarelli, S; Pisconti, S; Nisi, C; Tamburini, E; Viola, M G; Lonardi, S; Cremolini, C; Iacono, D; Tagliaferri, P; Pietrantonio, F; Tortora, G; Rosati, G; Zampino, M G; Curigliano, G; Febbraro, A; Normanno, N; De Vita, F; Fazio, N; Ciardiello, F; Martini, G

Effectiveness of FTD/TPI plus bevacizumab and impact of prior bevacizumab exposure in patients with mCRC: the Italian FLOWER study

FTD/TPI联合贝伐单抗治疗mCRC患者的疗效及既往贝伐单抗暴露的影响:意大利FLOWER研究

Trovato, G; Carullo, M; Nicastro, A; Spoto, C; Perissinotto, E; Giordano, G; Di Giacomo, E; Calegari, M A; Pasquinucci, V; Troiani, T; Tamberi, S; Schirripa, M; Scartozzi, M; Morano, F; Arrivi, G; Morelli, C; Basso, M; Landi, M; Martinelli, E; Zoratto, F; Bergamo, F; Landriscina, M; Lucchetti, J; Cremolini, C; Tortora, G; Salvatore, L

Atezolizumab plus bevacizumab as first-line treatment of unresectable hepatocellular carcinoma: interim analysis results from the phase IIIb AMETHISTA trial

阿特珠单抗联合贝伐珠单抗一线治疗不可切除肝细胞癌:AMETHISTA IIIb期试验的中期分析结果

Piscaglia, F; Masi, G; Martinelli, E; Cabibbo, G; Di Maio, M; Gasbarrini, A; Iavarone, M; Antonuzzo, L; Mazzaferro, V; Ballestrero, A; Garufi, C; Bergamo, F; Celsa, C; Marino, D; Tovoli, F; Ponziani, F R; Pressiani, T; Astolfi, C; Gazzoli, G C; Ciardiello, F; Daniele, B; Rimassa, L

Comprehensive genomic profiling by liquid biopsy portrays metastatic colorectal cancer mutational landscape to predict antitumor efficacy of FOLFIRI plus cetuximab in the CAPRI-2 GOIM trial

通过液体活检进行全面的基因组分析,可以描绘转移性结直肠癌的突变图谱,从而预测 CAPRI-2 GOIM 试验中 FOLFIRI 联合西妥昔单抗的抗肿瘤疗效。

Ciardiello, D; Boscolo Bielo, L; Napolitano, S; Latiano, T P; De Stefano, A; Tamburini, E; Toma, I; Bordonaro, R; Russo, A E; Pisconti, S; Nisi, C; Lotesoriere, C; Vallarelli, S; Lonardi, S; Iacono, D; Cremolini, C; Tortora, G; Tagliaferri, P; Pietrantonio, F; Rosati, G; Lucenti, A; Scartozzi, M; Brunetti, O; Cinieri, S; Zampino, M G; Zaniboni, A; Berardi, R; Paoletti, G; Febbraro, A; Martinelli, E; Troiani, T; Cioli, E; Normanno, N; Di Maio, M; Parente, P; Fazio, N; Curigliano, G; De Vita, F; Avallone, A; Maiello, E; Ciardiello, F; Martini, G

Comprehensive genomic profiling by liquid biopsy in refractory metastatic colorectal cancer patients who are candidate for anti-EGFR rechallenge therapy: findings from the CAVE-2 GOIM trial

对符合抗EGFR再挑战治疗条件的难治性转移性结直肠癌患者进行液体活检的全面基因组分析:CAVE-2 GOIM试验的结果

Ciardiello, D; Boscolo Bielo, L; Pietrantonio, F; Martini, G; Troiani, T; Martinelli, E; Natangelo, S; Bosco, M F; Pisconti, S; Nisi, C; Tortora, G; Salvatore, L; Sartore-Bianchi, A; Siena, S; Blasi, L; Messina, M; Ongaro, E; Zaniboni, A; Pinto, C; Antonuzzo, L; Avallone, A; Normanno, N; Santabarbara, G; Zampino, M G; Berardi, R; Cogoni, A A; Leo, S; Lotesoriere, C; Latiano, T P; Maiello, E; Fazio, N; Curigliano, G; Bordonaro, R; De Vita, F; Ciardiello, F; Napolitano, S

Efficacy and safety of atezolizumab plus bevacizumab in MSI-like metastatic colorectal cancer: a multicenter, single-arm, phase II, open-label clinical trial

阿特珠单抗联合贝伐珠单抗治疗微卫星不稳定性样转移性结直肠癌的疗效和安全性:一项多中心、单臂、II期、开放标签临床试验

Elez, E; Siena, S; Sartore-Bianchi, A; Ros, J; Ciardello, F; Martinelli, E; Steeghs, N; Huijberts, S; Cervantes, A; Roselló, S; Tejpar, S; Wilmsen, B; Salazar, R; Santos, C; de Schaetzen, G; Muñoz, S; Bernards, R; Moreno, V; García-Galera, E; Alemany, R; Gros, A; Bardelli, A; Arena, S; Piris, A; Chavarría, E; Dienstmann, R; Tabernero, J

Genomic profiling of high tumor mutational load in microsatellite-stable colorectal cancer uncovers MAPK signaling pathway alterations following anti-EGFR therapy

对微卫星稳定型结直肠癌中高肿瘤突变负荷的基因组分析揭示了抗EGFR治疗后MAPK信号通路的改变

Boscolo Bielo, L; Napolitano, S; Avallone, A; Pietrantonio, F; Bordonaro, R; Maiello, E; Pisconti, S; Tamburini, E; Lotesoriere, C; Tortora, G; Zaniboni, A; Blasi, L; Antonuzzo, L; Berardi, R; Tagliaferri, P; Cremolini, C; Lonardi, S; Garufi, C; Pinto, C; Ongaro, E; Santabarbara, G; Scartozzi, M; De Falco, V; De Stefano, A; Cardone, C; Iacovucci, A; Bosco, M F; Russo, A E; Latiano, T P; Nisi, C; Messina, M; Salmistraro, N; Sartore-Bianchi, A; Siena, S; Zampino, M G; Fazio, N; Normanno, N; Febbraro, A; Guerrera, L P; Parente, P; De Vita, F; Martinelli, E; Troiani, T; Curigliano, G; Ciardiello, F; Martini, G; Ciardiello, D

Off-label drug use in oncology: integrating molecular and genetic analysis in an academic center's real-world approach

肿瘤学中的超适应症用药:将分子和遗传分析整合到学术中心的实际应用中

Cioli, E; Suarato, G; Napolitano, R; Caraglia, F; Esposito, A; Giugliano, C M; Cozzolino, S; Forte, M; Laudato, M P; Martinelli, E; De Vita, F; Morgillo, F; Orditura, M; Fasano, M; Napolitano, S; Della Corte, C M; Martini, G; Ciardiello, F; Troiani, T; De Falco, V

Targeting KRAS(G12C) in colorectal cancer: the beginning of a new era

靶向KRAS(G12C)治疗结直肠癌:新时代的开始

Ciardiello, D; Maiorano, B A; Martinelli, E